Accuray (ARAY) Presents New Data Showing TomoTherapy System Superior to RapidArc in Achieving Local Control of ... - StreetInsider.com

Canada NewsWire

Accuray (ARAY) Presents New Data Showing TomoTherapy System Superior to RapidArc in Achieving Local Control of ... StreetInsider.com These results should be further explored in a randomized trial." The study titled, "Clinical outcomes of several IMRT techniques for patients with head and neck cancer: A propensity score weighted analysis," provides results for 166 patients. It ... (ARAY) With Shares Trading unchanged at $4.60 New Data Show TomoTherapy® System…Finance Daily all 3 news articles »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uehIGc
via IFTTT